MoneyWorks4Me

A decent increase of about 72.70% in the turnover to Rs. 210.59 millions was observed for the quarter ended December 2023. The turnover stood at Rs. 121.94 millions during the similar quarter previous year.Profit for the quarter ended December 2023 rises by 50.90% to Rs. 27.75  millions from Rs. 18.39 millions.Operating profit for the quarter ended December 2023 rose to 38.60 millions as compared to 26.46 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 210.59 121.94 72.70 587.23 517.37 13.50 744.57 693.94 7.30
Other Income 3.68 1.27 189.76 11.49 5.06 127.08 8.41 8.82 -4.65
PBIDT 38.60 26.46 45.88 97.63 89.31 9.32 117.94 99.62 18.39
Interest 0.17 0.42 -59.52 0.79 0.84 -5.95 1.58 2.25 -29.78
PBDT 38.43 26.04 47.58 96.84 88.47 9.46 116.36 101.87 14.22
Depreciation 1.35 1.46 -7.53 3.99 4.38 -8.90 5.69 6.33 -10.11
PBT 37.08 24.58 50.85 92.85 84.09 10.42 110.67 95.54 15.84
TAX 9.33 6.19 50.73 23.82 21.17 12.52 28.63 23.31 22.82
Deferred Tax 0.00 0.00 0.00 0.46 -0.25 -284.00 -0.07 -0.01 600.00
PAT 27.75 18.39 50.90 69.03 62.92 9.71 82.04 72.23 13.58
Equity 57.57 57.57 0.00 57.57 57.57 0.00 57.57 57.57 0.00
PBIDTM(%) 18.33 21.70 -15.53 16.63 17.26 -3.69 15.84 14.36 10.34
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..